Corona 'Bancovid' vaccine invented by Bangladeshi company Globe Biotech is capable of preventing corona.
Globe Biotech Limited, a Bangladeshi research institute, has taken another step towards success in developing the vaccine for deadly Kovid-19. The first D714G variant of the mRNA-based vaccine in the world invented by Globe Biotech is capable of resisting the bancovid coronavirus, according to the US Medical Journal Bioarchive. They have also published a report on their website.
A press conference is scheduled to be held next week to prepare for the pre-clinical trial of the vaccine. The details will be presented at the press conference held at Tejgaon in the capital, the organization said.
According to Globe Biotech scientists, the vaccine has recently passed 100% of the safety and efficacy criteria. It was then sent to various international science journals for research.
Earlier, Globe Biotech Limited announced the discovery of corona vaccine in the country at a press conference on July 2. It was informed at that time that the first trial on animal carcass was completed at the research center located at Rupganj in Narayanganj. After that the rest of the research work was done in Tejgaon lab of the capital.
It is to be mentioned that for the first time in the country, Globe Biotech Limited, a pharmaceutical company, has demanded the discovery of a vaccine against Kovid-19 disease. They have also started research on ‘Globe Biotech Limited’ research for national and international needs as well as research on Covid-19 ‘detection kits, vaccines and medicines’.
Globe Biotech Limited started its journey in 2015 by setting up state-of-the-art laboratories for the production of biologics, novel drugs and biosimilars for the treatment of cancer, arthritis, anemia, hypertension, autoimmune diseases and other incurable diseases.
